• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    7/17/24 1:28:51 PM ET
    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ADTX alert in real time by email

    Shares of ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) fell sharply during Wednesday's session after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for voluntary liquidation.

    ASLAN Pharmaceuticals shares dipped 38.7% to $0.68 on Wednesday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • Aptevo Therapeutics Inc. (NASDAQ:APVO) shares climbed 84% to $0.6073 after surging around 10% on Tuesday. Aptevo Therapeutics recently announced closing of $2.75 million offering.
    • Shimmick Corporation (NASDAQ:SHIM) shares climbed 49% to $3.0173 after the company received a $27.6 million subcontract for the Sunol Valley Water Treatment Plant Ozonation Project.
    • Aditxt, Inc. (NASDAQ:ADTX) shares climbed 45.3% to $2.3107. Aditxt and Evofem amended merger agreement.
    • Locafy Limited (NASDAQ:LCFY) gained 31.2% to $7.15.
    • Autonomix Medical, Inc. (NASDAQ:AMIX) jumped 27.2% to $1.3505.
    • Alpha Teknova, Inc. (NASDAQ:TKNO) gained 18% to $1.60. Alpha Teknova 10% owner Telegraph Hill Partners Management Company, LLC bought a total of 12,096,773 shares at an average price of $1.24.
    • Asset Entities Inc. (NASDAQ:ASST) shares climbed 17% to $1.8350.
    • Meiwu Technology Company Limited (NASDAQ:WNW) gained 17% to $1.0650
    • Aehr Test Systems (NASDAQ:AEHR) gained 16.4% to $19.60 after the company reported better-than-expected Q4 financial results and issued FY25 revenue guidance above estimates. Also, the company announced it entered into a stock purchase agreement and made $12.7 million in orders for its FOX WaferPak full wafer Contractors.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) rose 14.5% to $0.2330. Allarity Therapeutics, last month, announced that it received notice from the NASDAQ Stock Market that it was granted a hearing.
    • ClearSign Technologies Corporation (NASDAQ:CLIR) gained 14.4% to $0.9499 as the company received initial order from Birwelco.
    • The Honest Company, Inc. (NASDAQ:HNST) gained 14% to $4.0350.
    • GLOBALFOUNDRIES Inc. (NASDAQ:GFS) climbed 12.7% to $61.36.
    • Bloom Energy Corporation (NYSE:BE) rose 9.4% to $16.50 after the company announced a strategic partnership with CoreWeave.
    • fuboTV Inc. (NYSE:FUBO) climbed 9.1% to $1.5610
    • GitLab Inc. (NASDAQ:GTLB) gained 8.4% to $54.92 following a report suggesting the company is exploring a sale.
    • Bloom Energy Corporation (NYSE:BE) rose 8% to $16.27 after the company announced a strategic partnership with CoreWeave.
    • V.F. Corporation (NYSE:VFC) gained 7.8% to $15.35 after the company announced it entered into a Stock and Asset Purchase Agreement to sell its Supreme brand to EssilorLuxottica for $1.5 billion in cash.

    Losers

    • Cassava Sciences, Inc. (NASDAQ:SAVA) fell 29.8% to $9.51 after announcing changes in executive leadership. The company named Rick Barry as Executive Chairman and Principal Executive Office and said Remi Barbier resigned as President, CEO, and Board Member.
    • 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) declined 20.9% to $21.16. 4DMT announced Phase 2 PRISM interim results for intravitreal 4D-150 in a broad wet AMD population affirming favorable safety profile and robust clinical activity.
    • Five Below, Inc. (NASDAQ:FIVE) shares dipped 19.7% to $81.93 after the company announced a CEO transition. Additionally, comparable sales decreased in the 10-week period ended July 13.
    • Sonim Technologies, Inc. (NASDAQ:SONM) fell 18.2% to $0.4138.
    • Adverum Biotechnologies, Inc. (NASDAQ:ADVM) dipped 16.3% to $7.46. Adverum Biotechnologies revealed 26-week interim analysis results of Ixo-vec from LUNA Phase 2 trial at 2024 ASRS Annual Meeting.
    • Structure Therapeutics Inc. (NASDAQ:GPCR) fell 16.2% to $37.44.
    • Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) fell 13.7% to $2.50.
    • Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) dipped 11.8% to $4.68.
    • Luminar Technologies, Inc. (NASDAQ:LAZR) fell 11.7% to $1.8974.
    • Viking Therapeutics, Inc. (NASDAQ:VKTX) dipped 10.8% to $50.89.
    • Onto Innovation Inc. (NYSE:ONTO) fell 10% to $214.17. Onto Innovation announced Dr. Stephen Schwartz has joined its board of directors.
    • ASML Holding N.V.  (NASDAQ:ASML) shares declined 9.8% to $963.01. ASML reported better-than-expected second-quarter earnings, driven by robust sales in China and a surge in new bookings.
    • Aurora Innovation, Inc. (NASDAQ:AUR) fell 9.5% to $4.46.
    • Nova Ltd. (NASDAQ:NVMI) declined 9.2% to $219.39.
    • Eightco Holdings Inc. (NASDAQ:OCTO) shares fell 9% to $0.48. Eightco Holdings recently said first-quarter revenue fell to $9.6 million from $15.9 million in the year-ago period.
    • Credo Technology Group Holding Ltd (NASDAQ:CRDO) dipped 8.8% to $30.87.
    • Siebert Financial Corp. (NASDAQ:SIEB) fell 8.5% to $1.7381 after gaining over 9% on Tuesday.
    • Spirit Airlines, Inc. (NYSE:SAVE) shares declined 8.4% to $2.8950 as the company issued soft second-quarter preliminary revenue estimates. The company estimated total revenue for the second quarter of 2024 to be approximately $1.28 billion, lower than previously expected primarily due to lower-than-expected non-ticket revenue.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares fell 8.1% to $1.3890 after jumping 41% on Tuesday.
    • Advanced Micro Devices, Inc. (NASDAQ:AMD) dipped 8% to $163.01.
    • Semtech Corporation (NASDAQ:SMTC) fell 7.4% to $33.66.
    • NaaS Technology Inc. (NASDAQ:NAAS) fell 7.3% to $4.32.
    • e.l.f. Beauty, Inc. (NYSE:ELF) declined 7.1% to $175.56.
    • Safe and Green Development Corporation (NASDAQ:SGD) shares dipped 7.1% to $0.38.
    • J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT) fell 7% to $163.74 after the company reported worse-than-expected second-quarter financial results.
    • QUALCOMM Incorporated (NASDAQ:QCOM) fell 6.5% to $195.94 after HSBC downgraded the stock from Buy to Hold.
    • Snap Inc. (NYSE:SNAP) fell 6.3% to $15.11 after Donald Trump made comments in support of TikTok.
    • NVIDIA Corporation (NASDAQ:NVDA) fell 5.2% to $119.82. Shares of semiconductor stocks traded lower amid reports Biden is considering further China restrictions.

    Now Read This:

    • Alphabet, CrowdStrike And 2 Other Stocks Insiders Are Selling
    Get the next $ADTX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADTX
    $ADVM
    $AEHR
    $ALLR

    CompanyDatePrice TargetRatingAnalyst
    NVIDIA Corporation
    $NVDA
    8/22/2025$190.00 → $214.00Outperform
    Evercore ISI
    GitLab Inc.
    $GTLB
    8/22/2025$50.00Neutral
    DA Davidson
    Five Below Inc.
    $FIVE
    8/22/2025$128.00 → $144.00Market Perform
    Telsey Advisory Group
    NVIDIA Corporation
    $NVDA
    8/21/2025$175.00 → $205.00Buy
    UBS
    Five Below Inc.
    $FIVE
    8/12/2025$165.00Hold → Buy
    Loop Capital
    e.l.f. Beauty Inc.
    $ELF
    8/8/2025$121.00Hold → Buy
    Deutsche Bank
    Advanced Micro Devices Inc.
    $AMD
    8/7/2025$165.00Sell → Hold
    DZ Bank
    The Honest Company Inc.
    $HNST
    8/7/2025$7.00 → $6.00Market Perform
    Telsey Advisory Group
    More analyst ratings

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

    For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

    11/9/23 2:30:20 PM ET
    $SRAX
    $SNAP
    Advertising
    Consumer Discretionary
    Computer Software: Programming Data Processing
    Technology

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    SEC Filings

    View All

    Semtech Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SEMTECH CORP (0000088941) (Filer)

    8/25/25 4:07:06 PM ET
    $SMTC
    Semiconductors
    Technology

    Advanced Micro Devices Inc. filed SEC Form 8-K: Leadership Update

    8-K - ADVANCED MICRO DEVICES INC (0000002488) (Filer)

    8/25/25 4:07:00 PM ET
    $AMD
    Semiconductors
    Technology

    SEC Form 425 filed by Asset Entities Inc.

    425 - Asset Entities Inc. (0001920406) (Subject)

    8/25/25 8:02:16 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Levitan Lauren Cooks was granted 1,203 shares, increasing direct ownership by 10% to 12,710 units (SEC Form 4)

    4 - e.l.f. Beauty, Inc. (0001600033) (Issuer)

    8/25/25 4:32:45 PM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Daniele Tiffany F. was granted 1,203 shares, increasing direct ownership by 21% to 6,837 units (SEC Form 4)

    4 - e.l.f. Beauty, Inc. (0001600033) (Issuer)

    8/25/25 4:31:02 PM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Watson Maureen C. was granted 1,642 shares, increasing direct ownership by 87% to 3,530 units (SEC Form 4)

    4 - e.l.f. Beauty, Inc. (0001600033) (Issuer)

    8/25/25 4:26:13 PM ET
    $ELF
    Package Goods/Cosmetics
    Consumer Discretionary

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP of ICS Mcgee Eric bought $161,553 worth of shares (1,148 units at $140.76) (SEC Form 4)

    4 - HUNT J B TRANSPORT SERVICES INC (0000728535) (Issuer)

    8/8/25 10:29:09 AM ET
    $JBHT
    Trucking Freight/Courier Services
    Industrials

    Director Donahoe John J bought $989,460 worth of shares (162,337 units at $6.10) (SEC Form 4)

    4 - Aurora Innovation, Inc. (0001828108) (Issuer)

    8/7/25 9:19:59 AM ET
    $AUR
    EDP Services
    Technology

    Director Carucci Richard bought $602,500 worth of shares (50,000 units at $12.05), increasing direct ownership by 22% to 280,282 units (SEC Form 4)

    4 - V F CORP (0000103379) (Issuer)

    5/27/25 6:14:33 AM ET
    $VFC
    Garments and Clothing
    Industrials

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Semtech Announces Second Quarter of Fiscal Year 2026 Results

    Record net sales of $257.6 million, representing 20% year-over-year growth GAAP gross margin of 52.1%, up from 49.0% a year ago and Non-GAAP adjusted gross margin of 53.2%, up from 50.4% a year ago GAAP operating margin of (6.3)% compared to 3.6% a year ago and Non-GAAP adjusted operating margin of 18.8% compared to 14.2% a year ago GAAP diluted loss per share of $0.31 compared to a diluted loss per share of $2.61 a year ago and Non-GAAP adjusted diluted earnings per share of $0.41 compared to $0.11 a year ago Semtech Corporation (NASDAQ:SMTC), a leading provider of high-performance semiconductor, Internet of Things ("IoT") systems and cloud connectivity service solutions, toda

    8/25/25 4:05:00 PM ET
    $SMTC
    Semiconductors
    Technology

    NVIDIA Blackwell-Powered Jetson Thor Now Available, Accelerating the Age of General Robotics

    News Summary: NVIDIA Jetson AGX Thor developer kit and production modules, robotics computers designed for physical AI and robotics, are now generally available.Over 2 million developers are using NVIDIA's robotics stack, with Agility Robotics, Amazon Robotics, Boston Dynamics, Caterpillar, Figure, Hexagon, Medtronic and Meta among early Jetson Thor adopters.Jetson Thor, powered by NVIDIA Blackwell, offers 7.5x more AI compute and 3.5x greater energy efficiency compared with its predecessor, Jetson Orin, unlocking real-time reasoning inference, critical for highly performant physical AI applications.Jetson Thor solves one of the most significant challenges in robotics: enabling robots to ha

    8/25/25 11:00:01 AM ET
    $NVDA
    Semiconductors
    Technology

    Aditxt's Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030

    Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt", or the "Company"), a social innovation platform accelerating promising health innovations, today announced an update on its wholly owned subsidiary Adimune, Inc. ("Adimune"), which is pioneering a DNA-based therapeutic platform designed to reprogram the immune system. Adimune's intellectual property portfolio now includes 96 granted and 22 pending patents that are owned or exclusively licensed by Aditxt, supporting the company's strategy to address the global autoimmune therapeutics market, which is estimated at over

    8/25/25 9:15:00 AM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evercore ISI reiterated coverage on NVIDIA with a new price target

    Evercore ISI reiterated coverage of NVIDIA with a rating of Outperform and set a new price target of $214.00 from $190.00 previously

    8/22/25 8:10:19 AM ET
    $NVDA
    Semiconductors
    Technology

    DA Davidson resumed coverage on GitLab with a new price target

    DA Davidson resumed coverage of GitLab with a rating of Neutral and set a new price target of $50.00

    8/22/25 8:01:47 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Telsey Advisory Group reiterated coverage on Five Below with a new price target

    Telsey Advisory Group reiterated coverage of Five Below with a rating of Market Perform and set a new price target of $144.00 from $128.00 previously

    8/22/25 7:51:52 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Leadership Updates

    Live Leadership Updates

    View All

    Bloom Energy Appoints Aaron Hoover to Lead Business and Corporate Development

    Long-time Global Co-Head of Energy Investment Banking at Morgan Stanley Joins Bloom at Time of Unprecedented Power Demand to Expand Energy Partnership Ecosystem  Bloom Energy (NYSE:BE), a global leader in power solutions, today announced that Aaron Hoover will join the company to head business and corporate development. In this role, he will develop and oversee strategic partnerships with energy ecosystem players and drive corporate development initiatives as Bloom advances its mission to deliver reliable, clean, and affordable energy. Mr. Hoover brings more than two decades of leadership experience in the energy and finance sectors. Most recently, he served as Global Co-Head of Energ

    8/21/25 4:05:00 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    Cassava Reports Q2 2025 Financials Results and Provides Business Update

    Following positive preclinical data, simufilam development to advance with a clinical study expected to begin in H1 2026 for the potential treatment of TSC-related epilepsyRecent appointment of experienced neuroscience leaders to guide the clinical development strategy for simufilamAdvanced settlement negotiations ongoing to resolve certain securities litigation; $31.25 million estimated loss contingency recorded in Q2 for resolution$112.4 million in cash and cash equivalents at June 30, 2025 AUSTIN, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ:SAVA, "Cassava", the "Company")), a biotechnology company focused on developing novel, investigational treatments for c

    8/14/25 7:30:00 AM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ibotta Names Matt Puckett as Chief Financial Officer

    Ibotta, Inc. (NYSE:IBTA), which operates the largest digital promotions network in North America, today announced the appointment of industry leader, Matt Puckett, as its new Chief Financial Officer (CFO), effective August 25. Puckett will lead Ibotta's financial strategy and operations, and investor relations as the Company continues its commitment to innovation in performance marketing for CPGs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250811800289/en/Matt Puckett "We are thrilled to welcome Matt to the Ibotta executive team," said Bryan Leach, founder and CEO of Ibotta. "His deep expertise in all aspects of financial st

    8/11/25 9:20:00 AM ET
    $IBTA
    $VFC
    Advertising
    Consumer Discretionary
    Garments and Clothing
    Industrials

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Spirit Airlines Inc.

    SC 13G - Spirit Airlines, Inc. (0001498710) (Subject)

    12/6/24 9:37:58 AM ET
    $SAVE
    Air Freight/Delivery Services
    Consumer Discretionary

    SEC Form SC 13G filed by Autonomix Medical Inc.

    SC 13G - Autonomix Medical, Inc. (0001617867) (Subject)

    12/3/24 6:17:58 PM ET
    $AMIX
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Autonomix Medical Inc.

    SC 13G - Autonomix Medical, Inc. (0001617867) (Subject)

    11/27/24 10:15:18 AM ET
    $AMIX
    Medical/Dental Instruments
    Health Care

    $ADTX
    $ADVM
    $AEHR
    $ALLR
    Financials

    Live finance-specific insights

    View All

    Semtech Announces Second Quarter of Fiscal Year 2026 Results

    Record net sales of $257.6 million, representing 20% year-over-year growth GAAP gross margin of 52.1%, up from 49.0% a year ago and Non-GAAP adjusted gross margin of 53.2%, up from 50.4% a year ago GAAP operating margin of (6.3)% compared to 3.6% a year ago and Non-GAAP adjusted operating margin of 18.8% compared to 14.2% a year ago GAAP diluted loss per share of $0.31 compared to a diluted loss per share of $2.61 a year ago and Non-GAAP adjusted diluted earnings per share of $0.41 compared to $0.11 a year ago Semtech Corporation (NASDAQ:SMTC), a leading provider of high-performance semiconductor, Internet of Things ("IoT") systems and cloud connectivity service solutions, toda

    8/25/25 4:05:00 PM ET
    $SMTC
    Semiconductors
    Technology

    GitLab To Announce Second Quarter Fiscal 2026 Financial Results

    All Remote - GitLab Inc., (NASDAQ:GTLB), the most comprehensive, intelligent DevSecOps platform, today announced that it will report its financial results for the second quarter of fiscal year 2026, which ended July 31, 2025, after U.S. markets close on Wednesday, September 3, 2025. Management will host a conference call and webcast on the same day to discuss the company's financial results at 4:30 p.m. ET / 1:30 p.m. PT. GitLab Second Quarter Fiscal 2026 Financial Results Conference Call and Webcast When: Wednesday, September 3, 2025 Time: 4:30 p.m. ET / 1:30 p.m. PT Earnings Call Registration Replay: A webcast replay of the conference call will be available on the investor relat

    8/20/25 4:05:00 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

    Study Achieves Primary and Secondary Endpoints, Demonstrating Statistically Significant Reductions in Body Weight with Once-Daily VK2735 Dosing as Compared to Placebo Up to 12.2% (26.6 lbs) Mean Weight Loss Observed After 13 Weeks of VK2735 Treatment Compared with 1.3% (2.9 lbs) for Placebo Exploratory Assessment of Low Dose Maintenance Treatment Demonstrates Positive Proof of Concept VK2735 Shown to be Safe and Well-Tolerated in 13-Week Study; 99% of GI-specific Treatment Emergent Adverse Events Considered Mild or Moderate Conference Call Scheduled for 8:00 a.m. ET Today SAN DIEGO, Aug. 19, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ:VKTX), a clinical-stage biopharmac

    8/19/25 7:08:00 AM ET
    $VKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care